Sulindac plus erlotinib reduces duodenal polyp burden

Combination therapy with sulindac and erlotinib reduced the burden of duodenal polyps in a preliminary study involving 92 patients with familial adenomatous polyposis (FAP), which was reported online...
Source: Family Practice News - Category: Primary Care Source Type: news